Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.4K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

4.1K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.1K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

1.1K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.1K
Pulmonary Function Tests01:25

Pulmonary Function Tests

1.0K
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
1.0K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

3.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.2K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.3K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Donor Pooling as an Effective Method to Increase MSC EV Production Without Compromising Therapeutic Potential.

Journal of extracellular biology·2026
Same author

Visibility of breathlessness in fibrotic interstitial lung disease: perceptions of international healthcare professionals.

ERJ open research·2026
Same author

Immunotherapy-related interstitial lung disease: a call to improve risk stratification and diagnostic consistency.

ERJ open research·2026
Same author

Olive Oil and the Impact of Gastrointestinal Adverse Events During Pirfenidone Treatment in Idiopathic Pulmonary Fibrosis: A Post-hoc Analysis of the MADIET Trial.

Archivos de bronconeumologia·2026
Same author

Protocol for the INterstitial lung Disease EXacerbations (INDEX) Study: a retrospective multicentre cohort study.

BMJ open respiratory research·2026
Same author

Application of the Idiopathic Pulmonary Fibrosis Patient-Reported Outcome Measure (IPF-PROM) scale to a Greek IPF patient population and its interrelation with depressive symptoms and health-related quality of life.

BMJ open respiratory research·2026

Related Experiment Video

Updated: Apr 3, 2026

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

1.4K

Interstitial lung disease fatigue and breathlessness (ILD-FAB) programme: a multidisciplinary feasibility study.

Jessica Mandizha1,2, Rebecca Davies3, Charlotte Crook3

  • 1University of Exeter, Exeter, UK j.mandizha2@exeter.ac.uk.

BMJ Open Respiratory Research
|April 1, 2026
PubMed
Summary

The Fatigue and Breathlessness (FAB) program, adapted for interstitial lung disease (ILD), shows promise in improving quality of life for patients. This ILD-FAB program is feasible, acceptable, and clinically effective for managing ILD symptoms.

Keywords:
Idiopathic Pulmonary FibrosisInterstitial Fibrosis

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

14.1K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.7K

Related Experiment Videos

Last Updated: Apr 3, 2026

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
04:24

Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease

Published on: September 5, 2025

1.4K
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

14.1K
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
07:10

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease

Published on: August 24, 2019

10.7K

Area of Science:

  • Pulmonary Medicine
  • Rehabilitation Medicine
  • Quality of Life Studies

Background:

  • Interstitial lung disease (ILD) significantly impacts quality of life due to prevalent symptoms like fatigue and breathlessness.
  • The Fatigue and Breathlessness (FAB) program supports self-management in chronic conditions.
  • Adapting the FAB program for ILD patients is explored to address their unique challenges.

Purpose of the Study:

  • To evaluate the feasibility, acceptability, and clinical effectiveness of an adapted FAB program for individuals with interstitial lung disease.
  • To assess the program's impact on managing breathlessness, fatigue, and overall well-being in ILD patients.

Main Methods:

  • A 4-week ILD-specific FAB program involving weekly group sessions led by an ILD physiotherapist and clinical nurse specialist (CNS).
  • Individualized 1:1 sessions with the ILD-CNS focusing on goal setting and cognitive behavioral therapy principles.
  • The Chronic Respiratory Questionnaire-Self Report (CRQ-SR) was used for pre- and post-program assessments of key symptoms and functioning.

Main Results:

  • 49 participants with various ILDs (idiopathic pulmonary fibrosis, progressive pulmonary fibrosis) and diverse lung function severity were enrolled.
  • High attendance rates (76% attended all 4 sessions) and strong program recommendation (100%) were observed.
  • Clinically significant improvements were noted in dyspnoea (59%), emotional functioning (51%), fatigue (49%), and mastery (49%) among participants who completed the program.

Conclusions:

  • The ILD-specific FAB program is feasible, acceptable, and clinically effective for improving patient-reported outcomes.
  • The program demonstrates potential for enhancing self-management and quality of life in individuals with interstitial lung disease.
  • Further research with larger cohorts and longitudinal outcome measures is warranted to solidify these findings.